ABN AMRO Bank N.V.

Bank

Position in JNJ — Johnson & Johnson

CIK 1561082 AMSTERDAM, P7

Position in JNJ

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$9,049,902

-$171,996 QoQ

Shares Held

37,023

-16.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ABN AMRO Bank N.V. holds $948,098,619 across 8 Drug Manufacturers - General names. JNJ ranks #6 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,445,171	$482,236,624
2	LLY	ELI LILLY & Co	239,700	$220,468,869
3	ABBV	AbbVie Inc.	864,389	$187,995,963
4	GILD	Gilead Sciences, Inc.	195,724	$27,278,053
5	MRK	Merck & Co., Inc.	147,377	$17,727,979
6	JNJ	Johnson & Johnson This page	37,023	$9,049,902
7	AMGN	Amgen Inc	5,506	$1,937,286
8	PFE	Pfizer Inc	49,998	$1,403,943

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,049,902	37,023	-16.9%	Shares	Sole	2026-04-22
2025-12-31	$9,221,898	44,561	+4.4%	Shares	Sole	2026-02-04
2025-09-30	$7,913,540	42,679	+1674.6%	Shares	Sole	2025-11-05
2025-06-30	$367,363	2,405	-27.9%	Shares	Sole	2025-08-12
2025-03-31	$553,242	3,336	+43.9%	Shares	Sole	2025-08-28
2024-12-31	$335,229	2,318	-0.7%	Shares	Sole	2025-08-28
2024-09-30	$378,248	2,334	+0.7%	Shares	Sole	2025-08-28
2024-06-30	$338,798	2,318	-7.9%	Shares	Sole	2025-08-28
2024-03-31	$398,322	2,518	-53.2%	Shares	Sole	2025-08-28
2023-12-31	$842,790	5,377	+13.5%	Shares	Sole	2025-08-28
2023-09-30	$737,787	4,737	+5.6%	Shares	Sole	2025-08-28
2023-06-30	$742,191	4,484	+18.9%	Shares	Sole	2025-08-28
2023-03-31	$584,505	3,771	—	Shares	Sole	2025-08-28
No filing history on record for this holder in this stock.